RSS   Newsletter   Contact   Advertise with us
Post Online Media

HealthCare Royalty Partners names managing director

HealthCare Royalty PartnersHealthCare Royalty Partners (HRC) announced that Warren Cooper has assumed the role of managing director and chief medical officer at HCR.
Article continues below

READ MORE Caladrius appoints Gregory R. Brown to its board

Dr. Cooper initially joined the team in 2016, consulting as an Industry Advisor. He is a UK-trained physician with over 35 years of experience in the global pharmaceutical industry.

HCR’s senior professionals have known Dr. Cooper for over a decade, working closely with him when he served as CEO of Prism Pharmaceuticals.

Prior to serving as CEO of Prism, Dr. Cooper spent 12 years with Merck, initially as a UK clinical research physician, then as head of European and subsequently Worldwide Clinical Research Operations.

Dr. Cooper also previously led AstraMerck’s (now AstraZeneca PLC) cardiovascular division.

HCR has promoted John Urquhart to a Principal of the firm.

Mr. Urquhart has over a decade of healthcare investing experience in the royalty and structured finance market.

Mr. Urquhart was among the first employees at HCR, joining the firm as an analyst in 2007 and re-joining in 2012 after receiving his M.B.A. from The Wharton School of the University of Pennsylvania.

HCR has also promoted Anthony Rapsomanikis to Vice President.

Mr. Rapsomanikis joined HCR as an Associate in 2012, and was promoted to Director of West Coast Business Development after establishing the firm’s San Francisco office in 2015.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy